Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19,714Revenue $M6,909Net Margin (%)9.0Z-Score1.9
Enterprise Value $M27,693EPS $1.6Operating Margin %16.4F-Score8
P/E(ttm))32.4Cash Flow Per Share $3.2Pre-tax Margin (%)10.8Higher ROA y-yY
Price/Book6.210-y EBITDA Growth Rate %12.7Quick Ratio1.0Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %7.1Current Ratio1.6Lower Leverage y-yY
Price/Cash Flow8.5y-y EBITDA Growth Rate %1.8ROA % (ttm)4.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)21.2Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M374ROI % (ttm)4.4Gross Margin Increase y-yY

Gurus Latest Trades with MYL

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLJean-Marie Eveillard 2014-03-31 Buy 0.09%$42.26 - $57.2
($48.38)
$ 52.348%New holding, 675428 sh.675,428
MYLDavid Dreman 2014-03-31 Sold Out $42.26 - $57.2
($48.38)
$ 52.348%Sold Out0
MYLJohn Hussman 2014-03-31 Reduce-0.47%$42.26 - $57.2
($48.13)
$ 52.349%Reduce -75%50,000
MYLScott Black 2014-03-31 Reduce-0.16%$42.26 - $57.2
($48.13)
$ 52.349%Reduce -10.63%274,571
MYLJoel Greenblatt 2014-03-31 Sold Out -0.01%$42.26 - $57.2
($48.38)
$ 52.348%Sold Out0
MYLDavid Dreman 2013-12-31 Buy $37.865 - $44.5
($41.09)
$ 52.3427%New holding, 1221 sh.1,221
MYLJoel Greenblatt 2013-12-31 Reduce$37.865 - $44.5
($41.09)
$ 52.3427%Reduce -31.83%7,291
MYLJohn Hussman 2013-12-31 Reduce-0.53%$37.865 - $44.5
($41.09)
$ 52.3427%Reduce -55.95%200,000
MYLScott Black 2013-12-31 Reduce-0.23%$37.865 - $44.5
($41.09)
$ 52.3427%Reduce -14.62%307,214
MYLJohn Hussman 2013-09-30 Reduce-0.48%$30.37 - $38.95
($35.23)
$ 52.3449%Reduce -43.25%454,000
MYLJoel Greenblatt 2013-09-30 Reduce-0.16%$30.37 - $38.95
($35.23)
$ 52.3449%Reduce -91.73%10,695
MYLRay Dalio 2013-09-30 Sold Out -0.02%$30.37 - $38.95
($35.23)
$ 52.3449%Sold Out0
MYLJohn Hussman 2013-06-30 Buy 1.1%$27.96 - $31.87
($29.87)
$ 52.3475%New holding, 800000 sh.800,000
MYLJoel Greenblatt 2013-06-30 Add0.15%$27.96 - $31.87
($29.87)
$ 52.3475%Add 668.47%129,295
MYLMario Gabelli 2013-06-30 Reduce$27.96 - $31.87
($29.87)
$ 52.3475%Reduce -35.28%13,000
MYLJohn Paulson 2013-06-30 Reduce-0.98%$27.96 - $31.87
($29.87)
$ 52.3475%Reduce -32.83%12,139,300
MYLRay Dalio 2013-06-30 Reduce-0.06%$27.96 - $31.87
($29.87)
$ 52.3475%Reduce -79.15%61,097
MYLVanguard Health Care Fund 2013-03-31 Buy 0.48%$27.45 - $31.01
($29.03)
$ 52.3480%New holding, 4176100 sh.4,176,100
MYLRay Dalio 2013-03-31 Add0.07%$27.45 - $31.01
($29.03)
$ 52.3480%Add 609.61%292,989
MYLJohn Paulson 2013-03-31 Reduce-1.08%$27.45 - $31.01
($29.03)
$ 52.3480%Reduce -26.24%18,073,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MYL Jean-Marie Eveillard 2014-03-31675,4280.180.09New Buy
MYL Vanguard Health Care Fund 2014-03-314,775,7001.280.66
MYL Mario Gabelli 2014-03-3113,00000
MYL John Paulson 2014-03-3112,130,7003.252.9-0.07%
MYL Scott Black 2014-03-31274,5710.071.5-10.63%
MYL John Hussman 2014-03-3150,0000.010.18-75%
MYL Joel Greenblatt 2014-03-31000Sold Out
MYL David Dreman 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DIMICK NEIL FDirector 2014-06-19Sell5,432$50.811.14view
Malik RajivPresident 2014-04-22Sell80,000$502.78view
BRESCH HEATHER MCEO 2014-04-14Sell75,000$46.0711.55view
DIMICK NEIL FDirector 2014-03-20Sell5,813$53.08-3.18view
TODD C BDirector 2014-03-14Sell10,000$53-3.04view
MAROON JOSEPH C MDDirector 2014-03-10Sell10,000$53.51-3.96view
KORMAN HARRYCOO 2014-03-06Sell31,970$54.54-5.78view
RIZZO DANIEL C JRSVP, Corp Controller & CAO 2014-03-03Sell8,003$55.5-7.41view
LEECH DOUGLAS JDirector 2014-03-03Sell10,000$55.4-7.24view
Mauro AnthonyPresident, North America 2014-03-03Sell20,000$54.81-6.24view

Press Releases about MYL :

    Quarterly/Annual Reports about MYL:

    News about MYL:

    Articles On GuruFocus.com
    Scott Black’s Top First Quarter Holdings Apr 23 2014 
    Should You Buy Actavis? Mar 18 2014 
    Scott Black’s Top Five Stocks at Year End Jan 09 2014 
    Scott Black’s Top Five Third Quarter Holdings Oct 22 2013 
    S&P Winners Broadly Held by Billionaires Oct 06 2013 
    Weekly CEO Sells Highlight: Workday Inc., Kirby Corp., Mylan Inc., Infinera Corporation Sep 09 2013 
    Three Stocks for a Recovering Europe Jul 29 2013 
    comment on MYL Jan 03 2013 
    comment on MYL Jan 01 2013 
    Weekly Top Insider Sells: FIS, MYL, LMCA Dec 24 2012 

    More From Our Partners
    Will Congress Scuttle the AbbVie-Shire Merger? Jul 18 2014 - FOXBUSINESS

    More From Other Websites
    Tax inversions allow firms to avoid state taxes Jul 21 2014
    Why Abbott's Stake In Mylan Will Be Value-Creative Jul 21 2014
    US companies sit at a crossroads on tax inversions Jul 19 2014
    Here’s the sad truth about tax-‘inversion’ deals Jul 18 2014
    AbbVie To Buy Shire For $54 Billion In Biggest Inversion Deal Ever Jul 18 2014
    Mylan, Clear Channel, Aereo, Globus: Intellectual Property Jul 17 2014
    Hatch Open to Some Near-Term Steps Addressing Inversions Jul 17 2014
    Acorda Therapeutics Sues Mylan Over Plan to Copy MS Drug Jul 17 2014
    Mylan Wins Permanent Block of Apotex Generic Paxil Sales Jul 17 2014
    Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No... Jul 17 2014
    Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No... Jul 17 2014
    Congress And Tax Inversions: A Wall Streeter's Take On 2014 Jul 16 2014
    Abbott, St. Jude Top Views, But Stocks Under Pressure Jul 16 2014
    [video] Treasury Secretary Urges Congress to Limit Corporate Inversion Transactions Jul 16 2014
    Treasury Urges Halt to Tax Inversion M&A 'Abuse' Jul 16 2014
    Slim chances seen for tax 'inversion' clampdown, analysts say Jul 16 2014
    Mylan (MYL) Joins the Tax-Inversion Wave Jul 16 2014
    Treasury calls on Congress to halt inversion deals Jul 16 2014
    Treasury Urges End to Foreign Tax Flights, but Quick Action Is Unlikely Jul 16 2014
    Abbott 2Q profit falls on higher taxes, revenue up Jul 16 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide